首页 | 本学科首页   官方微博 | 高级检索  
     


Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)
Authors:Manuela Schmidinger  Aristotelis Bamias  Giuseppe Procopio  Robert Hawkins  Angel Rodriguez Sanchez  Sergio Vázquez  Narayanan Srihari  Haralabos Kalofonos  Petri Bono  Chaitali Babanrao Pisal  Yulia Hirschberg  Luca Dezzani  Qasim Ahmad  Eric Jonasch  on behalf of the PRINCIPAL Study Group
Affiliation:1. Medical University of Vienna, Vienna, Austria;2. National and Kapodistrian University of Athens Alexandra Hospital, Athens, Greece;3. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;4. The Christie Hospital and University of Manchester, Manchester, United Kingdom;5. University Hospital of Leon, Leon, Spain;6. Hospital Universitario Lucus Augusti, Lugo, Spain;7. Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, United Kingdom;8. University of Patras, Patras, Greece;9. Helsinki University Hospital and University of Helsinki, Helsinki, Finland;10. Novartis Healthcare Private Limited, Hyderabad, India;11. Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA;12. The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Abstract:
Keywords:Renal cell carcinoma  Pazopanib  Real-world  Observational  Tyrosine kinase inhibitor
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号